Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
Mebendazole, a well-known anti-helminthic drug in wide clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical studies across a number of different cancer types. Significantly, there are also two case reports of anti-cancer activity in humans. The data are...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Cancer Intelligence
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096024/ |